Medrisesp. z o.o.
Research and experimental development in natural sciences and engineering
Overview
Medrise is a clinical research center established in 2023 by a group of experienced physicians. The company conducts clinical trials for new drugs and therapies targeting various diseases, including ulcerative colitis and Crohn's disease.
Financials
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2023-11-01. Active
52 1090 2688 0000 0001 5387 0002
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 27, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $22,614 | OIC Poland Fundacja Akademii Wsei |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Wit Cezary Danilkiewicz (66) | 34 | $459.21 | 34% |
Paweł Marcin Iberszer (55) | 33 | $445.71 | 33% |
Maciej Putowski (33) | 33 | $445.71 | 33% |
Beneficial owners
| Person | Rights |
|---|---|
Paweł Marcin Iberszer (55)  | Shareholder of a limited liability company, 2300.0 PLN |
Maciej Putowski (33) | Shareholder of a limited liability company, 2250.0 PLN |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| BiokineticaS.A. | $1,292,838.89 | biokinetica.com | |
| Saventic Healthsp. z o.o. | $1,089,246.05 | saventic.com | |
| Centrum Badawcze Panaceum Agnieszka Brzezicka,Magdalena Lenkiewiczsp. z o.o. | $1,087,310.46 | klinikabadawcza.pl | |
| Centrum Alergologiisp. z o.o. | $812,503.07 | centrumalergologii.pl | |
| Reumedikasp. z o.o. | $323,427.61 | reumedika.pl | |
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | |
| CCTSsp. z o.o. | $281,193.31 | ccts.pl | |
| Specjalistyczne Gabinetysp. z o.o. | $239,872.14 | specjalistycznegabinety.pl | |
| Dicellasp. z o.o. | $206,073.49 | dicella.com | |
| Oncotarget Wojciech JurczakS.K.A. | $192,291.27 | oncotarget.pl |
Change history
| Date | Event |
|---|---|
| 2025-10-31 | PKD change (Removed: 72.19.Z; Added: 72.10.Z, 86.21.Z, 86.22.Z, 86.99.D) |
| 2023-04-19 | Entered in the register |
FAQ
Last updated: 2026-04-08